comparemela.com

Latest Breaking News On - Thomas yip - Page 4 : comparemela.com

DURECT Corporation s (DRRX) CEO Jim Brown on Q2 2022 Results - Earnings Call Transcript

DURECT Corporation (NASDAQ:NASDAQ:DRRX) Q2 2022 Earnings Conference Call August 4, 2022, 4:30 PM ET Company Participants Tim Papp - Chief Financial Officer Jim Brown - Chief Executive.

United statesEd arceKristen kluskaRick millerTim pappJim brownThomas yipFrancois briseboisNorman sussmanCompany participantsUs patent officeCantor fitzgeraldDurect corporationCorporation second quarterUnited states to innocoll pharmaceuticalsConference call august

AcelRx Pharmaceuticals, Inc (ACRX) CEO Vincent Angotti on Q1 2022 Results - Earnings Call Transcript

AcelRx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ACRX) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Raffi Asadorian - Chief Financial Officer Vincent Angotti -.

United statesSouth koreaEd arcePam palmerVince angottiPamela palmerVincent angottiRaffi asadorianThomas yipRobert leboyerBrandon folkesCompany participantsDepartment of defenseExchange commissionCantor fitzgeraldAcelrx pharmaceuticals inc

Arcturus Therapeutics Holdings Inc (ARCT) CEO Joseph Payne on Q1 2022 Results - Earnings Call Transcript

Arcturus Therapeutics Holdings Inc. (NASDAQ:NASDAQ:ARCT) Q1 2022 Results Earnings Conference Call May 9, 2022, 04:30 PM ET Company Participants Deepankar Roy - Senior Director, Investor.

Republic ofUnited statesUnited kingdomHan iKumar rajaEd arceRaymond jamesJoseph payneDeepankar roySteven seedhouseBevan wangYigal nochomovitzNick abbottPiper sandlerSeamus fernandezAndy sassine

Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q1 2022 Results - Earnings Call Transcript

Nabriva Therapeutics plc (NASDAQ:NASDAQ:NBRV) Q1 2022 Earnings Conference Call May 05, 2022 04:30 PM ET Company Participants Dan Dolan - Chief Financial Officer Ted Schroeder - Chief.

United statesEd arceCarl byrnesThomas yipDan dolanTed schroederChristine guico pabiaCompany participantsNabriva therapeuticsConference call mayNabriva therapeutics first quarterChief financialChief executive officerNorthland capitalLincoln parkChief medical

DURECT Corp (DRRX) CEO James Brown on Q1 2022 Results - Earnings Call Transcript

DURECT Corp, Inc. (NASDAQ:NASDAQ:DRRX) Q1 2022 Earnings Conference Call May 04, 2022, 16:30 ET Company Participants Matthew Hogan - IR James Brown - Co-Founder, CEO, President &.

United statesSan franciscoMatt hoganKristen kluskaJames brownMatthew hoganEdward arceThomas yipFrancois briseboisNorman sussmanCompany participantsNature communicationsDurect corp incUnited states to innocoll pharmaceuticalsScripps instituteCantor fitzgerald

vimarsana © 2020. All Rights Reserved.